Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2025

Aug 19, 2025

30718_dirs_2025-08-19_33f9e72d-de25-4a64-bd86-ece8ce2da8a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-08-15

Reporting Person: McManus Matthew (President - Diag & Spatial Bio)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-15 Common Stock M 2637 Acquired 5615 Direct
2025-08-15 Common Stock F 880 $53.60 Disposed 4735 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-08-15 Restricted Stock Units $ M 2637 Disposed Common Stock (2637) Direct
2025-08-15 Performance Restricted Stock Units $ A 19243 Acquired Common Stock (19243) Direct
2025-08-15 Restricted Stock Units $ A 9622 Acquired Common Stock (9622) Direct
2025-08-15 Stock Option (Right to Buy) $53.60 A 24614 Acquired 2035-08-15 Common Stock (24614) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Performance Restricted Stock Units $ Common Stock (2888) 2888 Direct
Performance Stock Option (Right to Buy) $68.54 2031-02-01 Common Stock (7951) 7951 Direct
Restricted Stock Units $ Common Stock (9241) 9241 Direct
Stock Option (Right to Buy) $68.54 2031-02-01 Common Stock (15902) 15902 Direct
Performance Restricted Stock Units $ Common Stock (15825) 15825 Direct
Stock Option (Right to Buy) $74.91 2034-08-15 Common Stock (21320) 21320 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F3: 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.

F4: Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.

F5: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: 2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.

F7: Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

F8: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F9: 3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.

F10: Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028.